CINV Corp works closely with the UK Conservative Drug Policy Reform Group (CDPRG) Chaired by Crispin Blunt MP, who advocate evidence-based drug policy.
The group exists to find and examine the evidence to support policymakers in reducing harm and securing the benefits of evidence-based drug policy.
The CDPRG act as an advisory panel for the JPD Capital group supported by their unenumerated Policy Council:
CINV Corp also works very closely with the Harare Institute for Technology (HIT), a Zimbabwe-based scientific institute dedicated to technopreneurial leadership. The HIT advisory panel works within the Research and Development function.
Professor Mazuru Gundidza is a professor of Medicinal Chemistry, Pharmacognosy, Biochemistry, Natural Medicine and Microbiology, at the Harare Institute of Technology. He is also a founding member of the newly formed Natural Therapists Council of Zimbabwe and is the principal advisor for CINV Corp and liaison for the HIT partnership, He currently serves as Chairman of the Pharmacy department for HIT.